OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis

M. Kloppenburg, E. Maheu, V. B. Kraus, F. Cicuttini, M. Doherty, R. L. Dreiser, Y. Henrotin, G. L. Jiang, L. Mandl, J. Martel-Pelletier, A. E. Nelson, T. Neogi, J. P. Pelletier, L. Punzi, R. Ramonda, L. S. Simon, S. Wang

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Hand osteoarthritis (OA) is a very frequent disease, but yet understudied. However, a lot of works have been published in the past 10 years, and much has been done to better understand its clinical course and structural progression. Despite this new knowledge, few therapeutic trials have been conducted in hand OA. The last OARSI recommendations for the conduct of clinical trials in hand OA dates back to 2006. The present recommendations aimed at updating previous recommendations, by incorporating new data. The purpose of this expert opinion, consensus driven exercise is to provide evidence-based guidance on the design, execution and analysis of clinical trials in hand OA, where published evidence is available, supplemented by expert opinion, where evidence is lacking, to perform clinical trials in hand OA, both for symptom and for structure-modification. They indicate core outcome measurement sets for studies in hand OA, and list the methods and instruments that should be used to measure symptoms or structure. For both symptom- and structure-modification, at least pain, physical function, patient global assessment, HR-QoL, joint activity and hand strength should be assessed. In addition, for structure-modification trials, structural progression should be measured by radiographic changes. We also provide a research agenda listing many unsolved issues that seem to most urgently need to be addressed from the perspective of performing "good" clinical trials in hand OA. These updated OARSI recommendations should allow for better standardizing the conduct of clinical trials in hand OA in the next future.

Original languageEnglish
Pages (from-to)772-786
Number of pages15
JournalOsteoarthritis and Cartilage
Volume23
Issue number5
DOIs
Publication statusPublished - 2015

Keywords

  • Clinical tools
  • Clinical trials guidelines
  • Hand osteoarthritis
  • Methodology
  • Radiological assessment
  • Recommendations osteoarthritis

Cite this

Kloppenburg, M. ; Maheu, E. ; Kraus, V. B. ; Cicuttini, F. ; Doherty, M. ; Dreiser, R. L. ; Henrotin, Y. ; Jiang, G. L. ; Mandl, L. ; Martel-Pelletier, J. ; Nelson, A. E. ; Neogi, T. ; Pelletier, J. P. ; Punzi, L. ; Ramonda, R. ; Simon, L. S. ; Wang, S. / OARSI Clinical Trials Recommendations : Design and conduct of clinical trials for hand osteoarthritis. In: Osteoarthritis and Cartilage. 2015 ; Vol. 23, No. 5. pp. 772-786.
@article{b1665368a60d44b78214c1fe016b0deb,
title = "OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis",
abstract = "Hand osteoarthritis (OA) is a very frequent disease, but yet understudied. However, a lot of works have been published in the past 10 years, and much has been done to better understand its clinical course and structural progression. Despite this new knowledge, few therapeutic trials have been conducted in hand OA. The last OARSI recommendations for the conduct of clinical trials in hand OA dates back to 2006. The present recommendations aimed at updating previous recommendations, by incorporating new data. The purpose of this expert opinion, consensus driven exercise is to provide evidence-based guidance on the design, execution and analysis of clinical trials in hand OA, where published evidence is available, supplemented by expert opinion, where evidence is lacking, to perform clinical trials in hand OA, both for symptom and for structure-modification. They indicate core outcome measurement sets for studies in hand OA, and list the methods and instruments that should be used to measure symptoms or structure. For both symptom- and structure-modification, at least pain, physical function, patient global assessment, HR-QoL, joint activity and hand strength should be assessed. In addition, for structure-modification trials, structural progression should be measured by radiographic changes. We also provide a research agenda listing many unsolved issues that seem to most urgently need to be addressed from the perspective of performing {"}good{"} clinical trials in hand OA. These updated OARSI recommendations should allow for better standardizing the conduct of clinical trials in hand OA in the next future.",
keywords = "Clinical tools, Clinical trials guidelines, Hand osteoarthritis, Methodology, Radiological assessment, Recommendations osteoarthritis",
author = "M. Kloppenburg and E. Maheu and Kraus, {V. B.} and F. Cicuttini and M. Doherty and Dreiser, {R. L.} and Y. Henrotin and Jiang, {G. L.} and L. Mandl and J. Martel-Pelletier and Nelson, {A. E.} and T. Neogi and Pelletier, {J. P.} and L. Punzi and R. Ramonda and Simon, {L. S.} and S. Wang",
year = "2015",
doi = "10.1016/j.joca.2015.03.007",
language = "English",
volume = "23",
pages = "772--786",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "Elsevier",
number = "5",

}

Kloppenburg, M, Maheu, E, Kraus, VB, Cicuttini, F, Doherty, M, Dreiser, RL, Henrotin, Y, Jiang, GL, Mandl, L, Martel-Pelletier, J, Nelson, AE, Neogi, T, Pelletier, JP, Punzi, L, Ramonda, R, Simon, LS & Wang, S 2015, 'OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis' Osteoarthritis and Cartilage, vol. 23, no. 5, pp. 772-786. https://doi.org/10.1016/j.joca.2015.03.007

OARSI Clinical Trials Recommendations : Design and conduct of clinical trials for hand osteoarthritis. / Kloppenburg, M.; Maheu, E.; Kraus, V. B.; Cicuttini, F.; Doherty, M.; Dreiser, R. L.; Henrotin, Y.; Jiang, G. L.; Mandl, L.; Martel-Pelletier, J.; Nelson, A. E.; Neogi, T.; Pelletier, J. P.; Punzi, L.; Ramonda, R.; Simon, L. S.; Wang, S.

In: Osteoarthritis and Cartilage, Vol. 23, No. 5, 2015, p. 772-786.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - OARSI Clinical Trials Recommendations

T2 - Design and conduct of clinical trials for hand osteoarthritis

AU - Kloppenburg, M.

AU - Maheu, E.

AU - Kraus, V. B.

AU - Cicuttini, F.

AU - Doherty, M.

AU - Dreiser, R. L.

AU - Henrotin, Y.

AU - Jiang, G. L.

AU - Mandl, L.

AU - Martel-Pelletier, J.

AU - Nelson, A. E.

AU - Neogi, T.

AU - Pelletier, J. P.

AU - Punzi, L.

AU - Ramonda, R.

AU - Simon, L. S.

AU - Wang, S.

PY - 2015

Y1 - 2015

N2 - Hand osteoarthritis (OA) is a very frequent disease, but yet understudied. However, a lot of works have been published in the past 10 years, and much has been done to better understand its clinical course and structural progression. Despite this new knowledge, few therapeutic trials have been conducted in hand OA. The last OARSI recommendations for the conduct of clinical trials in hand OA dates back to 2006. The present recommendations aimed at updating previous recommendations, by incorporating new data. The purpose of this expert opinion, consensus driven exercise is to provide evidence-based guidance on the design, execution and analysis of clinical trials in hand OA, where published evidence is available, supplemented by expert opinion, where evidence is lacking, to perform clinical trials in hand OA, both for symptom and for structure-modification. They indicate core outcome measurement sets for studies in hand OA, and list the methods and instruments that should be used to measure symptoms or structure. For both symptom- and structure-modification, at least pain, physical function, patient global assessment, HR-QoL, joint activity and hand strength should be assessed. In addition, for structure-modification trials, structural progression should be measured by radiographic changes. We also provide a research agenda listing many unsolved issues that seem to most urgently need to be addressed from the perspective of performing "good" clinical trials in hand OA. These updated OARSI recommendations should allow for better standardizing the conduct of clinical trials in hand OA in the next future.

AB - Hand osteoarthritis (OA) is a very frequent disease, but yet understudied. However, a lot of works have been published in the past 10 years, and much has been done to better understand its clinical course and structural progression. Despite this new knowledge, few therapeutic trials have been conducted in hand OA. The last OARSI recommendations for the conduct of clinical trials in hand OA dates back to 2006. The present recommendations aimed at updating previous recommendations, by incorporating new data. The purpose of this expert opinion, consensus driven exercise is to provide evidence-based guidance on the design, execution and analysis of clinical trials in hand OA, where published evidence is available, supplemented by expert opinion, where evidence is lacking, to perform clinical trials in hand OA, both for symptom and for structure-modification. They indicate core outcome measurement sets for studies in hand OA, and list the methods and instruments that should be used to measure symptoms or structure. For both symptom- and structure-modification, at least pain, physical function, patient global assessment, HR-QoL, joint activity and hand strength should be assessed. In addition, for structure-modification trials, structural progression should be measured by radiographic changes. We also provide a research agenda listing many unsolved issues that seem to most urgently need to be addressed from the perspective of performing "good" clinical trials in hand OA. These updated OARSI recommendations should allow for better standardizing the conduct of clinical trials in hand OA in the next future.

KW - Clinical tools

KW - Clinical trials guidelines

KW - Hand osteoarthritis

KW - Methodology

KW - Radiological assessment

KW - Recommendations osteoarthritis

UR - http://www.scopus.com/inward/record.url?scp=84933514588&partnerID=8YFLogxK

U2 - 10.1016/j.joca.2015.03.007

DO - 10.1016/j.joca.2015.03.007

M3 - Review Article

VL - 23

SP - 772

EP - 786

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 5

ER -